Research
-
Diagnoses and Treatment of Behavioral and Psychological Symptoms of Dementia Among Racially and Ethnically Diverse Persons Living with Dementia
Lower rates of behavioral and psychological symptoms of dementia diagnoses in non-white compared to white populations may indicate underdiagnosis in clinical settings of treatable conditions.
Categorized in -
Predicting Pressure Injury Risk in Hospitalised Patients Using Machine Learning with Electronic Health Records: a US Multilevel Cohort Study
The predictive algorithm with features generated by machine learning achieved significantly improved prediction of pressure injury risk.
Categorized in -
Comparative Effectiveness of Placental Allografts in the Treatment of Diabetic Lower Extremity Ulcers and Venous Leg Ulcers in U.S. Medicare Beneficiaries: A Retrospective Observational Cohort Study Using Real-World Evidence
DLEUs and VLUs treated with vCPM and vLPM allografts are associated with lowered 1-year mortality, wound recurrence, and AOs in DLEUs and VLUs compared with standard care. Decision makers weighing coverage of placental allografts should consider these added short- and long-term clinical benefits relative to costly management and high mortality of Medicare’s most frequent wounds.
Categorized in -
Prevalence of Medical Payment Products Promoted on US Hospitals’ Websites
Research findings suggest that policies limiting hospitals’ promotion of MPPs may need to be coupled with efforts to stabilize hospital finances, as hospitals may be using MPP promotion when they lack the resources to offer long-term interest-free financing.
Categorized in -
Trauma Center Hospitals Charged Higher Prices For Some Nontrauma Care Than Non–Trauma Center Hospitals, 2012–18
Hospitals designated as trauma centers charged higher prices for nontrauma inpatient admissions and nontrauma emergency department visits when compared with hospitals that were not designated as trauma centers.
Categorized in -
Medicare Part D Plans Greatly Increased Utilization Restrictions On Prescription Drugs, 2011–20
Part D plans became significantly more restrictive over time, rising from an average of 31.9 percent of compounds restricted in 2011 to 44.4 percent restricted in 2020.
Categorized in -
Analysis of Agreement Between Measures of Subjective Cognitive Impairment and Probable Dementia in the National Health and Aging Trends Study
Subjective cognitive impairment was more prevalent than probable dementia
Categorized in -
Risk Preferences Over Health: Empirical Estimates and Implications for Medical Decision-Making
Individuals are risk-seeking at low levels of health and are most risk-averse at perfect health
Categorized in -
Pharmaceutical Pricing That Balances Innovation and Affordability for Patients with Rare Diseases
Alternative financing mechanisms for drugs that deliver significant long-term value for patients could strike a balance between encouraging innovation and accessibility.
-
A Principled Approach to Non‑Discrimination in Cost‑Effectiveness
Generalized Risk-Adjusted Cost-Effectiveness (GRACE) offers a choice-consistent alternative that admits a premium for disease severity and avoids prohibited discrimination under well-defined conditions on utility and the effects of disability.
Categorized in